[go: up one dir, main page]

IL165195A0 - A buffered, liquid nicotine composition for pulmonary administration - Google Patents

A buffered, liquid nicotine composition for pulmonary administration

Info

Publication number
IL165195A0
IL165195A0 IL16519504A IL16519504A IL165195A0 IL 165195 A0 IL165195 A0 IL 165195A0 IL 16519504 A IL16519504 A IL 16519504A IL 16519504 A IL16519504 A IL 16519504A IL 165195 A0 IL165195 A0 IL 165195A0
Authority
IL
Israel
Prior art keywords
buffered
pulmonary administration
liquid nicotine
nicotine composition
composition
Prior art date
Application number
IL16519504A
Other languages
English (en)
Original Assignee
Pfizer Health Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Health Ab filed Critical Pfizer Health Ab
Publication of IL165195A0 publication Critical patent/IL165195A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL16519504A 2002-06-03 2004-11-14 A buffered, liquid nicotine composition for pulmonary administration IL165195A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0201669A SE0201669D0 (sv) 2002-06-03 2002-06-03 New formulation and use thereof
PCT/SE2003/000890 WO2003101454A1 (fr) 2002-06-03 2003-05-30 Composition nicotinique liquide tamponnee pour administration dans les poumons

Publications (1)

Publication Number Publication Date
IL165195A0 true IL165195A0 (en) 2005-12-18

Family

ID=20288046

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16519504A IL165195A0 (en) 2002-06-03 2004-11-14 A buffered, liquid nicotine composition for pulmonary administration

Country Status (19)

Country Link
EP (1) EP1509227B9 (fr)
JP (2) JP4745658B2 (fr)
CN (1) CN100500148C (fr)
AR (1) AR039947A1 (fr)
AT (1) ATE444753T1 (fr)
AU (1) AU2003243074B2 (fr)
BR (1) BR0311451A (fr)
CA (1) CA2487699C (fr)
DE (1) DE60329592D1 (fr)
DK (1) DK1509227T3 (fr)
ES (1) ES2332405T3 (fr)
IL (1) IL165195A0 (fr)
MX (1) MXPA04012041A (fr)
NZ (1) NZ536863A (fr)
RU (1) RU2283111C2 (fr)
SE (1) SE0201669D0 (fr)
TW (1) TW200407142A (fr)
WO (1) WO2003101454A1 (fr)
ZA (1) ZA200409793B (fr)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
ATE359075T1 (de) 2002-12-20 2007-05-15 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
CN100381083C (zh) 2003-04-29 2008-04-16 韩力 一种非可燃性电子喷雾香烟
CN2719043Y (zh) * 2004-04-14 2005-08-24 韩力 雾化电子烟
PT1773816E (pt) 2004-06-24 2015-04-29 Vertex Pharma Moduladores de transportadores de cassete de ligação de atp
US20160345631A1 (en) 2005-07-19 2016-12-01 James Monsees Portable devices for generating an inhalable vapor
RS55940B1 (sr) 2005-12-28 2017-09-29 Vertex Pharma Čvrsti oblici n-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksohinolin-3-karboksamida
CA2646942C (fr) 2006-03-16 2014-07-29 Niconovum Ab Composition amelioree de tabac a priser
CN201067079Y (zh) 2006-05-16 2008-06-04 韩力 仿真气溶胶吸入器
NZ583848A (en) * 2007-09-14 2012-07-27 Vertex Pharma Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
AT507187B1 (de) 2008-10-23 2010-03-15 Helmut Dr Buchberger Inhalator
CN201379072Y (zh) 2009-02-11 2010-01-13 韩力 一种改进的雾化电子烟
EP2821400B1 (fr) 2009-03-20 2017-09-27 Vertex Pharmaceuticals Incorporated Procédé pour faire des modulateurs de régulateur de conductance transmembranaire de la fibrose kystique
AU2010295883B2 (en) * 2009-09-16 2015-08-20 Philip Morris Products Sa Improved device and method for delivery of a medicament
WO2012106739A1 (fr) 2011-02-11 2012-08-16 Helmut Buchberger Élément inhalateur
AT510837B1 (de) 2011-07-27 2012-07-15 Helmut Dr Buchberger Inhalatorkomponente
US8903228B2 (en) 2011-03-09 2014-12-02 Chong Corporation Vapor delivery devices and methods
EP2683431B1 (fr) 2011-03-09 2017-01-18 Chong Corporation Système d'administration de médicament
US9399110B2 (en) 2011-03-09 2016-07-26 Chong Corporation Medicant delivery system
US20140202476A1 (en) 2011-09-06 2014-07-24 British American Tobacco (Investments) Limited Heating smokeable material
PT3811800T (pt) 2011-09-06 2023-04-28 Nicoventures Trading Ltd Aquecimento de material fumável
US9907748B2 (en) * 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
AT511344B1 (de) 2011-10-21 2012-11-15 Helmut Dr Buchberger Inhalatorkomponente
MX2014010253A (es) 2012-02-27 2014-11-12 Vertex Pharma Composicion farmaceutica y administraciones de la misma.
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
GB2504075A (en) 2012-07-16 2014-01-22 Nicoventures Holdings Ltd Electronic smoking device
GB2504076A (en) 2012-07-16 2014-01-22 Nicoventures Holdings Ltd Electronic smoking device
GB201215273D0 (en) 2012-08-28 2012-10-10 Kind Consumer Ltd Nicotine composition
GB201215282D0 (en) 2012-08-28 2012-10-10 Kind Consumer Ltd An inhaler
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
GB2513637A (en) 2013-05-02 2014-11-05 Nicoventures Holdings Ltd Electronic cigarette
GB2513639A (en) 2013-05-02 2014-11-05 Nicoventures Holdings Ltd Electronic cigarette
RU2659887C2 (ru) * 2013-05-06 2018-07-04 Джуул Лэбз, Инк. Составы на основе солей никотина для аэрозольных устройств и способы их применения
US11202470B2 (en) 2013-05-22 2021-12-21 Njoy, Inc. Compositions, devices, and methods for nicotine aerosol delivery
GB2514893B (en) 2013-06-04 2017-12-06 Nicoventures Holdings Ltd Container
US10251422B2 (en) 2013-07-22 2019-04-09 Altria Client Services Llc Electronic smoking article
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
GB2560652B8 (en) 2013-12-23 2018-12-19 Juul Labs Uk Holdco Ltd Vaporization device systems and methods
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
GB201407426D0 (en) 2014-04-28 2014-06-11 Batmark Ltd Aerosol forming component
US10508096B2 (en) 2014-05-27 2019-12-17 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
CN113816940A (zh) * 2014-05-27 2021-12-21 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体络合物
US9896429B2 (en) 2014-05-27 2018-02-20 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
GB2528673B (en) 2014-07-25 2020-07-01 Nicoventures Holdings Ltd Aerosol provision system
RU2749213C2 (ru) 2014-10-07 2021-06-07 Вертекс Фармасьютикалз Инкорпорейтед Сокристаллы модуляторов регулятора трансмембранной проводимости при кистозном фиброзе
GB2535427A (en) 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
GB2532062A (en) * 2014-11-07 2016-05-11 Nicoventures Holdings Ltd Container
EP3226704B1 (fr) 2014-12-05 2021-01-20 Juul Labs, Inc. Commande de dose graduée
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201505595D0 (en) 2015-03-31 2015-05-13 British American Tobacco Co Cartridge for use with apparatus for heating smokeable material
GB201505597D0 (en) 2015-03-31 2015-05-13 British American Tobacco Co Article for use with apparatus for heating smokable material
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
GB201511361D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic vapour provision system
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
GB201516729D0 (en) * 2015-09-22 2015-11-04 The Technology Partnership Plc Liquid nicotine formulation
GB2542838B (en) 2015-10-01 2022-01-12 Nicoventures Trading Ltd Aerosol provision system
US20170119046A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Apparatus for Heating Smokable Material
CN114656446A (zh) * 2015-11-25 2022-06-24 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体配合物
US9867397B2 (en) 2016-01-11 2018-01-16 Patrick Beymer Nicotine delivery system
EP3419443A4 (fr) 2016-02-11 2019-11-20 Juul Labs, Inc. Cartouches fixées de manière sure pour des dispositifs de vaporisation
EP3413960B1 (fr) 2016-02-11 2021-03-31 Juul Labs, Inc. Cartouche de vaporisateur remplissable et procédé de remplissage
CA3015306A1 (fr) * 2016-02-29 2017-09-08 Nicogen Ltd. Formulation de nicotine et aerosols
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
UA123636C2 (uk) 2016-04-27 2021-05-05 Ніковенчерз Холдінгс Лімітед Електронна система утворення аерозолю і випаровувач для неї
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
EP3644771A4 (fr) * 2017-06-26 2021-11-17 Nude Nicotine, Inc. Sels de nicotine et procédés pour les préparer et les utiliser
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
GB2569940B (en) * 2017-11-01 2022-10-19 Nicoventures Trading Ltd Aerosolisable formulation
EP3574902A1 (fr) * 2018-06-01 2019-12-04 Yatzz Limited Formulation de nicotine et mode d'administration
GB201817867D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817860D0 (en) 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
GB201817863D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817859D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817864D0 (en) 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
US11399562B2 (en) 2019-06-07 2022-08-02 Ncp Nextgen A/S Oral pouched product
EP3905908B1 (fr) 2019-06-20 2025-01-08 Shaheen Innovations Holding Limited Dispositif d'atomisation à ultrasons personnel
EP4031218A4 (fr) 2019-12-15 2023-06-07 Shaheen Innovations Holding Limited Nébulisateur à ultrasons
US11730193B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
US12233207B2 (en) 2019-12-15 2025-02-25 Shaheen Innovations Holding Limited Mist inhaler devices
US12121056B2 (en) 2019-12-15 2024-10-22 Shaheen Innovations Holding Limited Hookah device
ES3028096T3 (en) 2019-12-15 2025-06-18 Shaheen Innovations Holding Ltd Ultrasonic mist inhaler
US11666713B2 (en) 2019-12-15 2023-06-06 Shaheen Innovations Holding Limited Mist inhaler devices
EP4292632B1 (fr) 2019-12-15 2025-08-27 Shaheen Innovations Holding Limited Nébulisateur à ultrasons
US11589610B2 (en) 2019-12-15 2023-02-28 Shaheen Innovations Holding Limited Nicotine delivery device having a mist generator device and a driver device
IL295717B2 (en) 2019-12-15 2024-05-01 Shaheen Innovations Holding Ltd Steam inhaler devices
US11730191B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
HUE067026T2 (hu) 2019-12-15 2024-09-28 Shaheen Innovations Holding Ltd Ultrahangos pára inhalátor
US12201144B2 (en) 2019-12-15 2025-01-21 Shaheen Innovations Holding Limited Hookah device
PL4031216T3 (pl) 2019-12-15 2025-06-09 Shaheen Innovations Holding Limited Mgiełkowy inhalator ultradźwiękowy
US20230188901A1 (en) 2021-12-15 2023-06-15 Shaheen Innovations Holding Limited Apparatus for transmitting ultrasonic waves

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2030862A (en) * 1978-04-10 1980-04-16 Smith A A composition for treating drug addiction such as smoking nicotine-containing products
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US4920989A (en) * 1985-04-25 1990-05-01 Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4953572A (en) * 1985-04-25 1990-09-04 Rose Jed E Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
GB9200047D0 (en) * 1992-01-03 1992-02-26 Univ Alberta Nicotine-containing nasal spray
RU2108089C1 (ru) * 1995-05-19 1998-04-10 Акционерное общество "Афродита" Шампунь для мытья волос
CN1159000C (zh) * 1996-05-13 2004-07-28 诺瓦提斯消费者保健股份有限公司 口腔释放系统

Also Published As

Publication number Publication date
CA2487699A1 (fr) 2003-12-11
JP2010280721A (ja) 2010-12-16
JP2005533770A (ja) 2005-11-10
CN100500148C (zh) 2009-06-17
AU2003243074A1 (en) 2003-12-19
CN1658876A (zh) 2005-08-24
MXPA04012041A (es) 2005-08-16
EP1509227B1 (fr) 2009-10-07
DE60329592D1 (de) 2009-11-19
JP5430525B2 (ja) 2014-03-05
AR039947A1 (es) 2005-03-09
ATE444753T1 (de) 2009-10-15
TW200407142A (en) 2004-05-16
DK1509227T3 (da) 2010-02-01
EP1509227A1 (fr) 2005-03-02
WO2003101454A1 (fr) 2003-12-11
NZ536863A (en) 2007-05-31
JP4745658B2 (ja) 2011-08-10
BR0311451A (pt) 2005-03-15
CA2487699C (fr) 2012-04-17
RU2283111C2 (ru) 2006-09-10
ZA200409793B (en) 2006-08-30
SE0201669D0 (sv) 2002-06-03
ES2332405T3 (es) 2010-02-04
EP1509227B9 (fr) 2010-05-19
AU2003243074B2 (en) 2008-11-20
RU2004139067A (ru) 2005-08-10

Similar Documents

Publication Publication Date Title
IL165195A0 (en) A buffered, liquid nicotine composition for pulmonary administration
IL158862A0 (en) An insulin composition for pulmonary administration
GB2394894B (en) New use for pharmaceutical composition
IL177798A0 (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
PL375551A1 (en) Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
IL191926A0 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
ZA200410295B (en) Medicament dispenser.
IL183706A0 (en) 2,4(4,6) pyrimidine derivatives
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
IL175127A0 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
AU3201701A (en) Pharmaceutical composition for pulmonary delivery
AU2003263113A8 (en) Dispensers particularly, but not exclusively, for cigarette packets
AU2001232017A1 (en) Pharmaceutical composition for pulmonary delivery
PT1838683E (pt) Um processo para a preparação de derivados de [1,4,5]-oxadiazepina
IL175023A0 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
IL182538A0 (en) 1,5-diheterocycle-1h-triazole derivative
GB0308771D0 (en) Pulmonary drug delivery
EP1515960A4 (fr) Derive de 2-thioxothiazole, procede de preparation de ce derive et composition pharmaceutique contenant ce derive
AU2003232684A8 (en) Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same
EP1693067A4 (fr) Composition pharmaceutique anti-herpetique, procede de production d'une forme medicamenteuse a partir de cette composition et procede d'utilisation correspondant
ZA200402034B (en) A pharmaceutical composition.
PL113640U1 (en) Dispenser, particularly for cigarettes
AU2003201624A1 (en) Compositions for pulmonary administration
AU2003303145A8 (en) Formulations for pulmonary delivery